Literature DB >> 11449860

Implementing a program for switching from i.v. to oral antimicrobial therapy.

A Wong-Beringer1, K H Nguyen, J Razeghi.   

Abstract

Management Case Studies describe approaches to real-life management problems in health systems. Each installment is a brief description of a problem and how it was dealt with. The cases are intended to help readers deal with similar experiences in their own work sites. Problem solving, not hypothesis testing, is emphasized. Successful resolution of the management issue is not a criterion for publication--important lessons can be learned from failures, too.

Mesh:

Substances:

Year:  2001        PMID: 11449860     DOI: 10.1093/ajhp/58.12.1146

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  5 in total

1.  Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study.

Authors:  Merisa Mok; Angus Kinkade; Anthony Tung; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2016-08-31

2.  Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital.

Authors:  Franky Buyle; Dirk Vogelaers; Renaat Peleman; Georges Van Maele; Hugo Robays
Journal:  Pharm World Sci       Date:  2010-04-01

3.  Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study.

Authors:  Vera von Gunten; Viviane Amos; Anne-Laure Sidler; Johnny Beney; Nicolas Troillet; Jean-Philippe Reymond
Journal:  Pharm World Sci       Date:  2003-04

4.  The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study.

Authors:  Bradley P Ho; Tim T Y Lau; Robert M Balen; Terryn L Naumann; Peter J Jewesson
Journal:  BMC Health Serv Res       Date:  2005-06-29       Impact factor: 2.655

5.  Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes.

Authors:  Sarah C J Jorgensen; Samantha L Yeung; Mira Zurayk; Jill Terry; Maureen Dunn; Paul Nieberg; Jean Pallares; Annie Wong-Beringer
Journal:  Open Forum Infect Dis       Date:  2018-05-02       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.